Key facts
- This page summarizes Daniel MacLachlan's Form 4 filing for Red Violet, Inc. (RDVT).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 10 Oct 2023, 18:25.
Daniel MacLachlan - 05 Oct 2023 Form 4 Insider Report for Red Violet, Inc. (RDVT)
- Reporting relationship
- Chief Financial Officer
- Issuer ticker
- RDVT
- Reported as of
- 05 Oct 2023
- Net transaction value
- -$90,062
- SEC form
- 4
- Accepted by SEC
- 10 Oct 2023, 18:25:08 UTC
- Prior SEC filing
- 13 Feb 2023
- Next SEC filing
- 30 Nov 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Daniel MacLachlan
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Daniel MacLachlan filed Form 4 for Red Violet, Inc. (RDVT) on 10 Oct 2023.
Change
- Previous filing in this sequence was filed on 13 Feb 2023.
- Current net transaction value: -$90,062.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
RDVT
transaction
Common Stock
Award
- Transaction value
- Shares
- +10,833
- Change %
- +3%
- Price
- Shares after
- 369,013
- Date
- 05 Oct 2023
- Ownership
- Direct
- Footnotes
- F1, F2, F3, F4
RDVT
transaction
Common Stock
Tax liability
- Transaction value
- $90,062
- Shares
- -4,588
- Change %
- -1.2%
- Price
- $19.63
- Shares after
- 364,425
- Date
- 05 Oct 2023
- Ownership
- Direct
- Footnotes
- F2, F3, F4, F5
RDVT
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 466
- Date
- 05 Oct 2023
- Ownership
- Held by IRA
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 5 footnotes
Footnote F1
Represents the second vesting of 10,833 restricted stock units (RSUs) of the grant originally approved by the Company's Compensation Committee on September 24, 2021.
Footnote F2
Includes 10,000 RSUs originally granted on November 20, 2020, convertible into common stock of the issuer on a one-for-one basis, which vests on November 1, 2023, subject to accelerated vesting under certain conditions.
Footnote F3
Includes 10,833 RSUs originally granted on September 24, 2021, convertible into common stock of the issuer on a one-for-one basis, which vests on October 1, 2024, subject to accelerated vesting under certain conditions.
Footnote F4
Includes 40,000 RSUs originally granted on October 12, 2022, convertible into common stock of the issuer on a one-for-one basis, which vest in three equal installments on each of November 1, 2023, November 1, 2024 and November 1, 2025, subject to accelerated vesting under certain conditions.
Footnote F5
Represents the disposition to issuer for tax obligations upon the vesting of RSUs.